Substance use disorder: contraceptive options counseling

What’s New in Contraception?

Contraceptive Technology Conference!

Biologic sexism of STIs

Excess breast cancer deaths after COVID-19

Contraception for patients with medical conditions

Pelvic Floor Dysfunction

Treating vulvodynia

Puzzling Over the Hurt Down-Under

Serious Mental Illness and Contraception

New 13-Cycle Vaginal Contraceptive System

The Future of Family Planning in Post-COVID America

New ASCCP Guidelines: Implications for FP

On the alert: mood disorders during 2020 stressors

Sex in the Time of COVID-19

Challenges old and new during the pandemic

Reproductive health in the time of Covid-19

Talking about toys

Missed Pills: The Problem That Hasn’t Gone Away

Find the “yes! . . . and” rather than “no” or “but”

Digital Family Planning: the Future is Now

Irregular Bleeding Due to Contraceptives

When she’s low on libido…

Ouch! Best approaches to menstrual pain

Contraceptive efficacy: understanding how user and method characteristics play their part

Strategizing treatment for chronic heavy menstrual bleeding


Untangling the literature on obesity and contraception

High tech apps for no-tech FABM

Menstrual exacerbation of other medical conditions

From Princeton University: Thomas James Trussell (1949-2018)

The Short and Long of IUD Use Duration

Selecting a Method When Guidance Isn’t Clear-cut

Healthcare in the Time of Digital Expansion

The Scoop on Two New FDA-Approved Contraceptive Methods

Pregnancy of unknown location—meeting the challenge

Big “yes” (with caveats) to CHCs during perimenopause

The role of IUDs (LNG IUDs, too!) in emergency contraception

Combined pills’ effect on mood disorders

Abortion in the U.S.: safe, declining, and under threat

Hope for ovarian cancer screening test

Breast cancer still a small risk with some hormonal contraceptives

New treatment modality for BV

Record rate of HPV-related throat cancer

Viruses in semen potentially transmissible

Don’t Abstain from Your Role in Abstinence

Teens births declining but geographic ‘hotspots’ defy trend

Online Medical Abortion Service Effective and Safe

Do Women Really Need to Wait That Long?

Reassuring news on depression and OC use

PMDD: Genetic clues may lead to improved treatment

Breast cancer risk when there is a family history

Body weight link to breast and endometrial cancers (and 11 others)

Family Planning in 2017 and Beyond

Make Me Cry: Depression Link (Again)?

Managing implant users’ bleeding and spotting

Zika: Updated guidance for providers

Pharmacist-prescribed contraceptives

Hot off the press! 2016 MEC and SPR

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Opioid use epidemic among reproductive-age women

Good news on the family planning home front!

War Against Planned Parenthood Hurts Women

Win-win for both treatment and prevention

Center of the Storm


Menopause, mood, mental acuity, and hormone therapy

Emergency contraception for teens

Postpartum Contraception: Now, Not Later

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Are we practicing what we preach?

Be alert to VTE in hormonal contraceptive users

LARC among teens increased 15-fold, but not enough

Brain cancer and hormonal contraception

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Alcohol consumption when pregnancy is unwanted or unintended

Latest Data on Contraceptive Use in the United States

LateBreaker sampler from Contraceptive Technology conference

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Handout on Unintended Pregnancy and Contraceptive Choice

Ask About Withdrawal (Really!)

Rules to Practice By: Safety First and Cleanliness is Close to. . .

What’s Vanity Fair Got Against the NuvaRing?

Promising New Treatment for Hepatitis C

Numbers matter, so make them simple for patients

The Recession’s Effect on Unintended Pregnancies

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Applying the “New” Cervical Cytology Guidelines in Your Practice

Acute Excessive Uterine Bleeding: New Management Strategies

Medical indications for IUD use in teens

Whatever happened to PID?

Update on Emergency Contraception New and Improved

Excess breast cancer deaths after COVID-19
July 2021


Over the next 10 years, the delay in screening, in conjunction with a delay in diagnostic tests, may result in a significant 1% increase in deaths due to related cancers, NCI director Norman Shipman wrote in a recent Science editorial.[1] By 2030, according to modeling figures, we may expect an additional 10,000 deaths due to the breast and colon cancers. This figure does not account for other cancer types or added health problems due to upstaging.


The pandemic especially affected screening rates in April 2020, when the CDC’s Early Detection Program showed an 87% decrease in breast cancer screening and 84% in cervical cancer screening.[2] The recommendations to stay home, fear over contracting COVID-19, and closure or suspension of screening services were posited as factors. As the year wore on, screenings ticked up some, but remained below pre-pandemic levels.

A study in Washington State compared the number of screening mammograms during April to December 2019 to the same time frame in 2020. In the study of 230 clinics and 8 hospitals, there was at an overall 49% decrease in screenings (55,678 screenings in 2019 vs 27522 in 2020).[3] More substantial declines appeared across certain racial and ethnic subgroups:

  • Hispanic: 64%
  • Native American/Alaska Native: 61%
  • Mixed race: 56%
  • Native Hawaiian/Pacific Islander: 54%
  • Asian 54%
  • Black 54%
  • Rural 59%
  • Urban 50%

The plunge in screening occurred on top of mammography screening rates were not stellar to begin with prior to the pandemic. In 2019, only 77% of women in the highest risk age category (50-74 years) reported having had a mammogram within the past 2 years. Rates dipped even lower among women in that age group who had less than a high school education (69%) or were at 200% below the poverty level (68%).[4] So when 2020 cut those mammogram screenings by half…well, you do the math.

[1] Sharpless NE. COVID-19 and cancer. Science 2020;368:1290

[2] Centers for Disease Control and Prevention. Sharp declines in breast andcervical cancer screening. Press release June 30, 2021.

[3] Amram O, Robison J, Amiri S, et al. Socioeconomic and racial inequities in breast cancer screening during the Covid-19 pandemic in Washington State. Research letter. JAMA NetWork Open 2021;4: e2110946. doi:10.1001 amram_2021_ld_210090_1620747010.03984

[4] National Cancer Institute. Cancer trends progress report. Data updated July 2021